American Vanguard Corp. (AVD) was Downgraded by BB&T Capital Mkts to ” Hold”. Earlier the firm had a rating of “Buy ” on the company shares. BB&T Capital Mkts advised their investors in a research report released on Jul 13, 2016.
On the company’s financial health, American Vanguard Corp. reported $0.10 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on May 3, 2016. Analyst had a consensus of $0.06. The company had revenue of $69.47 million for the quarter, compared to analysts expectations of $71.77 million. The company’s revenue was up 4.4% compared to the same quarter last year.
American Vanguard Corp. opened for trading at $15.34 and hit $15.73 on the upside on Monday, eventually ending the session at $15.72, with a gain of 2.34% or 0.36 points. The heightened volatility saw the trading volume jump to 1,08,728 shares. Company has a market cap of $458 M.
In a different news, on May 9, 2016, Ulrich Trogele (officer ) purchased 15,000 shares at $13.25 per share price.
American Vanguard Corporation (AVD) operates as a holding company. The Company is primarily a specialty chemical manufacturer that develops and markets products for agricultural commercial and consumer uses. It manufactures and formulates chemicals for crops human and animal protection. It conducts its business through its subsidiaries which include AMVAC Chemical Corporation (AMVAC) GemChem Inc. 2110 Davie Corporation Quimica Amvac de Mexico S.A. de C.V. AMVAC Mexico Sociedad de Responsabilidad Limitada AMVAC de Costa Rica Sociedad de Responsabilidad Limitada AMVAC Switzerland GmbH AMVAC do Brasil Representacoes Ltda AMVAC CV AMVAC Netherlands BV and Envance Technologies LLC. AMVAC is its main operating subsidiary which owns and/or operates its domestic manufacturing facilities. AMVAC manufactures formulates packages and sells its products in the United States. AMVAC markets insecticides fungicides herbicides molluscicides growth regulators and soil fumigants.